{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:52:56Z","timestamp":1790009576879,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbi.2021.07.026","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:23:21Z","timestamp":1628148201000},"page":"59-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Neurogenic and anti-inflammatory effects of probiotics in Parkinson\u2019s disease: A systematic review of preclinical and clinical evidence"],"prefix":"10.1016","volume":"98","author":[{"given":"Valentina","family":"Leta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ray Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Chung-Faye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Metta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine M.","family":"Pariante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Borsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbi.2021.07.026_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2021.07.026_b0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnins.2019.00328","article-title":"Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson's Disease","volume":"13","author":"Alecu","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2021.07.026_b0015","first-page":"1","article-title":"Neuroprotective effects of probiotics bacteria on animal model of Parkinson's disease induced by 6-hydroxydopamine: a behavioral, biochemical, and histological study","author":"Alipour Nosrani","year":"2020","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.bbi.2021.07.026_b0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","article-title":"Insulin resistance and Parkinson's disease: a new target for disease modification?","volume":"145\u2013146","author":"Athauda","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbi.2021.07.026_b0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3233\/JPD-171192","article-title":"Is exenatide a treatment for Parkinson's Disease?","volume":"7","author":"Athauda","year":"2017","journal-title":"J. Parkinson's Dis."},{"key":"10.1016\/j.bbi.2021.07.026_b0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/gut.46.2.218","article-title":"Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon","volume":"46","author":"Barcelo","year":"2000","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.bbi.2021.07.026_b0035","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","article-title":"Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT","volume":"87","author":"Barichella","year":"2016","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.bbi.2021.07.026_b0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/nu11040890","article-title":"From probiotics to psychobiotics: live beneficial bacteria which act on the brain-gut axis","volume":"11","author":"Berm\u00fadez-Humar\u00e1n","year":"2019","journal-title":"Nutrients."},{"issue":"s2","key":"10.1016\/j.bbi.2021.07.026_b0045","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.3233\/JPD-191711","article-title":"Increasing comparability and utility of gut microbiome studies in Parkinson's disease: a systematic review","volume":"9","author":"Boertien","year":"2019","journal-title":"J. Parkinson's Dis."},{"key":"10.1016\/j.bbi.2021.07.026_b0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbi.2017.05.006","article-title":"Rescue of IL-1beta-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants","volume":"65","author":"Borsini","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2021.07.026_b0055","doi-asserted-by":"crossref","unstructured":"Borsini, A., A. Cattaneo, C. Malpighi, S. Thuret, N.A. Harrison, M.R.C.I. Consortium, P.A. Zunszain, C.M. Pariante. 2018. Interferon-alpha reduces human hippocampal neurogenesis and increases apoptosis via activation of distinct STAT1-dependent mechanisms. Int. J. Neuropsychopharmacol. 21:187-200.","DOI":"10.1093\/ijnp\/pyx083"},{"key":"10.1016\/j.bbi.2021.07.026_b0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ijnp\/pyx083","article-title":"Pro- and anti-inflammatory properties of interleukin (IL6) in vitro: relevance for major depression and for human hippocampal neurogenesis","volume":"21","author":"Borsini","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2021.07.026_b0065","first-page":"289","article-title":"The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson's Disease: a randomized, double-blind PlaceboControlled Trial","volume":"21","author":"Borzabadi","year":"2018","journal-title":"Arch. Iranian Med."},{"key":"10.1016\/j.bbi.2021.07.026_b0070","first-page":"117","article-title":"Use of probiotics for the treatment of constipation in Parkinson's disease patients","volume":"57","author":"Cassani","year":"2011","journal-title":"Minerva Gastroenterol. Dietol."},{"issue":"5","key":"10.1016\/j.bbi.2021.07.026_b0075","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.18632\/aging.102927","article-title":"Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson's disease models","volume":"12","author":"Castelli","year":"2020","journal-title":"Aging"},{"issue":"20","key":"10.1016\/j.bbi.2021.07.026_b0080","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.3390\/ijms20205068","article-title":"PPAR\u03b3 and cognitive performance","volume":"20","author":"d\u2019Angelo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2021.07.026_b0085","doi-asserted-by":"crossref","unstructured":"Dimidi, E., S. Christodoulides, K.C. Fragkos, S.M. Scott, and K. Whelan. 2014. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am. J Clin. Nutrit. 100:1075\u20131084.","DOI":"10.3945\/ajcn.114.089151"},{"issue":"3","key":"10.1016\/j.bbi.2021.07.026_b0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3945\/an.116.014407","article-title":"Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation","volume":"8","author":"Dimidi","year":"2017","journal-title":"Adv Nutr."},{"issue":"5","key":"10.1016\/j.bbi.2021.07.026_b0095","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.neurobiolaging.2013.11.001","article-title":"Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease","volume":"35","author":"Dunn","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2021.07.026_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02062-2","article-title":"The impact of dextran sodium sulphate and probiotic pre-treatment in a murine model of Parkinson's disease","volume":"18","author":"Dwyer","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbi.2021.07.026_b0105","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2147\/CIA.S106284","article-title":"Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope?","volume":"11","author":"Georgescu","year":"2016","journal-title":"Clin. Interv. Aging"},{"issue":"2","key":"10.1016\/j.bbi.2021.07.026_b0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.celrep.2019.12.078","article-title":"Probiotic Bacillus subtilis protects against \u03b1-synuclein aggregation in C. elegans","volume":"30","author":"Goya","year":"2020","journal-title":"Cell reports."},{"key":"10.1016\/j.bbi.2021.07.026_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-3-5","article-title":"Interleukin-1 mediates Alzheimer and Lewy body pathologies","volume":"3","author":"Griffin","year":"2006","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.bbi.2021.07.026_b0120","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bja.2019.07.026","article-title":"Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential","volume":"123","author":"Guo","year":"2019","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.026_b0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Movem. Disorders."},{"issue":"6","key":"10.1016\/j.bbi.2021.07.026_b0130","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2014.01.052","article-title":"Compositional and functional features of the gastrointestinal microbiome and their effects on human health","volume":"146","author":"Hollister","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbi.2021.07.026_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Method."},{"key":"10.1016\/j.bbi.2021.07.026_b0140","first-page":"1","article-title":"The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?","volume":"3","author":"Houser","year":"2017","journal-title":"npj Parkinson's Dis."},{"issue":"4","key":"10.1016\/j.bbi.2021.07.026_b0145","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/brainsci10040206","article-title":"Probiotics alleviate the progressive deterioration of motor functions in a mouse model of Parkinson's Disease","volume":"10","author":"Hsieh","year":"2020","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.026_b0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9996","key":"10.1016\/j.bbi.2021.07.026_b0155","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet (London, England)."},{"issue":"8","key":"10.1016\/j.bbi.2021.07.026_b0160","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/mds.25736","article-title":"Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease","volume":"29","author":"Kelly","year":"2014","journal-title":"Movem. Dis."},{"key":"10.1016\/j.bbi.2021.07.026_b0165","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/bs.pbr.2020.01.004","article-title":"The gut microbiome in Parkinson's disease: A culprit or a bystander?","volume":"252","author":"Keshavarzian","year":"2020","journal-title":"Prog. Brain Res."},{"issue":"11","key":"10.1016\/j.bbi.2021.07.026_b0170","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","article-title":"Pathogenesis of Parkinson disease\u2013the gut-brain axis and environmental factors","volume":"11","author":"Klingelhoefer","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2021.07.026_b0175","unstructured":"Konnova, E.A., and M. Swanberg. 2018. Animal Models of Parkinson\u2019s Disease. In Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. T.B. Stoker and J.C. Greenland, editors. Codon Publications. Copyright: The Authors., Brisbane (AU)."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.026_bib351","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3233\/JPD-212570","article-title":"Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson\u2019s Disease: A Longitudinal Analysis of Two International Cohorts","volume":"11","author":"Leta","year":"2021","journal-title":"J Parkinsons Dis."},{"key":"10.1016\/j.bbi.2021.07.026_b0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbi.2020.07.036","article-title":"Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease","volume":"90","author":"Liao","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.bbi.2021.07.026_b0185","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol."},{"issue":"10","key":"10.1016\/j.bbi.2021.07.026_b0190","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s12272-018-1063-x","article-title":"Abnormal hippocampal neurogenesis in Parkinson's disease: relevance to a new therapeutic target for depression with Parkinson's disease","volume":"41","author":"Lim","year":"2018","journal-title":"Arch Pharm Res."},{"key":"10.1016\/j.bbi.2021.07.026_b0195","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fimmu.2019.00969","article-title":"Probiotics may have beneficial effects in Parkinson's disease: in vitro evidence","volume":"10","author":"Magistrelli","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2021.07.026_b0200","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on human health","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2021.07.026_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11274-020-02879-2","article-title":"Protective effects of Lactobacillus fermentum U-21 against paraquat-induced oxidative stress in Caenorhabditis elegans and mouse models","volume":"36","author":"Marsova","year":"2020","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbi.2021.07.026_b0210","first-page":"1","article-title":"Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation","author":"Metta","year":"2021","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.026_b0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/07315724.2018.1487346","article-title":"The effects of probiotic formulation pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a Lipopolysaccharide Rat Model","volume":"38","author":"Mohammadi","year":"2019","journal-title":"J. Am. Coll. Nutr."},{"issue":"7","key":"10.1016\/j.bbi.2021.07.026_b0220","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.bbi.2021.07.026_b0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota-brain axis in behaviour and brain disorders","volume":"19","author":"Morais","year":"2021","journal-title":"Nat Rev Microbiol."},{"key":"10.1016\/j.bbi.2021.07.026_b0230","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/mds.28119","article-title":"Meta-analysis of gut dysbiosis in Parkinson's disease","volume":"35","author":"Nishiwaki","year":"2020","journal-title":"Movem. Disord."},{"key":"10.1016\/j.bbi.2021.07.026_b0235","doi-asserted-by":"crossref","unstructured":"Perez Vis\u00f1uk, D., G. Savoy de Giori, J.G. LeBlanc, and A. de Moreno de LeBlanc. 2020. Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson's disease model. Nutrition (Burbank, Los Angeles County, Calif.). 79:110995.","DOI":"10.1016\/j.nut.2020.110995"},{"issue":"12","key":"10.1016\/j.bbi.2021.07.026_b0240","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Movem. Disorders"},{"key":"10.1016\/j.bbi.2021.07.026_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2020.12.026","article-title":"Prebiotic and probiotic supplementation and the tryptophan-kynurenine pathway: a systematic review and meta analysis","volume":"123","author":"Purton","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2021.07.026_b0250","first-page":"1","article-title":"Insights into neuroinflammation in Parkinson's disease: from biomarkers to anti-inflammatory based therapies","volume":"2015","author":"Rocha","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bbi.2021.07.026_b0255","doi-asserted-by":"crossref","unstructured":"Romano, S., G.M. Savva, J.R. Bedarf, I.G. Charles, F. Hildebrand, and A. Narbad. 2020. Meta-analysis of the gut microbiome of Parkinson's disease patients suggests alterations linked to intestinal inflammation. medRxiv: 1397.","DOI":"10.1101\/2020.08.10.20171397"},{"issue":"7","key":"10.1016\/j.bbi.2021.07.026_b0260","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.026_b0265","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Movem. Dis."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.026_b0270","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Movem. Disorders"},{"issue":"21","key":"10.1016\/j.bbi.2021.07.026_b0275","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.3390\/molecules25214891","article-title":"Probiotics in treatment of viral respiratory infections and neuroinflammatory disorders","volume":"25","author":"Shahbazi","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bbi.2021.07.026_b0280","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Shults","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2021.07.026_b0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbi.2021.07.026_b0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jnutbio.2019.03.021","article-title":"Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity","volume":"69","author":"Srivastav","year":"2019","journal-title":"J. Nutrit. Biochem."},{"issue":"l4898","key":"10.1016\/j.bbi.2021.07.026_b0295","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clin. Res. ed.)"},{"issue":"7660","key":"10.1016\/j.bbi.2021.07.026_b0300","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize \u03b1-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2021.07.026_b0305","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.bbi.2021.07.026_b0310","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s40265-015-0420-z","article-title":"Exenatide extended-release: an updated review of its use in type 2 diabetes mellitus","volume":"75","author":"Syed","year":"2015","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bbi.2021.07.026_b0315","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji","year":"2019","journal-title":"Clin. Nutrit."},{"key":"10.1016\/j.bbi.2021.07.026_b0320","first-page":"772","article-title":"Probiotics for constipation in Parkinson's disease: a randomized placebo-controlled study","volume":"5","author":"Tan","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2021.07.026_b0325","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.bbi.2021.07.026_b0330","first-page":"100270","article-title":"Kynurenine pathway in Parkinson's disease-An update","volume":"21","author":"Venkatesan","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbi.2021.07.026_b0335","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","article-title":"Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens","volume":"6","author":"Wallen","year":"2020","journal-title":"npj Parkinson's Dis."},{"issue":"11","key":"10.1016\/j.bbi.2021.07.026_b0340","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3390\/microorganisms8111661","article-title":"Probiotics treatment improves hippocampal dependent cognition in a rodent model of Parkinson's Disease","volume":"8","author":"Xie","year":"2020","journal-title":"Microorganisms."},{"key":"10.1016\/j.bbi.2021.07.026_b0345","doi-asserted-by":"crossref","unstructured":"Xin, J., D. Zeng, H. Wang, N. Sun, A. Khalique, Y. Zhao, L. Wu, K. Pan, B. Jing, and X. Ni. 2020. Lactobacillus johnsonii BS15 improves intestinal environment against fluoride-induced memory impairment in mice-a study based on the gut-brain axis hypothesis. PeerJ. 8:1012.","DOI":"10.7717\/peerj.10125"},{"issue":"6","key":"10.1016\/j.bbi.2021.07.026_b0350","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jnc.14928","article-title":"Enteric short-chain fatty acids promote proliferation of human neural progenitor cells","volume":"154","author":"Yang","year":"2020","journal-title":"J. Neurochem."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121002907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121002907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:12:35Z","timestamp":1760170355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159121002907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":71,"alternative-id":["S0889159121002907"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2021.07.026","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurogenic and anti-inflammatory effects of probiotics in Parkinson\u2019s disease: A systematic review of preclinical and clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2021.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}